PPARA and liver disorder: Pterostilbene’s lipid-lowering effects may mimic those of peroxisome proliferator-activated receptor alpha (PPAR-α) agonists, known to reduce lipogenesis and lipid peroxidation, which are key drivers of multiorgan diseases such as liver disease and heart failure.18